Helicobacter pylori Extract Induces Nuclear Factor-kappa B, Activator Protein-1, and Cyclooxygenase-2 in Esophageal Epithelial Cells

Journal of Gastrointestinal Surgery

Volumn 10, Issue 4, 2006, Pages 551-562

  Abdel Latif, Mohamed M M ^a   Windle, Henry ^a   Terres, Ana ^a   Eidhin, Déirdre Ní ^a   Kelleher, Dermot ^a   Reynolds, John V ^a  

^a Dublin Molecular Medicine Centre   (Ireland)

Author keywords

AP 1; esophageal cancer; H pylori; HPE; NF B

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTIOXIDANT; ASCORBIC ACID; CELL EXTRACT; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; ENZYME INHIBITOR; FLAVONOID; IMIDAZOLE DERIVATIVE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; PROTEIN KINASE (CALCIUM,CALMODULIN); PYRIDINE DERIVATIVE; TRANSCRIPTION FACTOR AP 1;

ARTICLE; BIOSYNTHESIS; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; EPITHELIUM CELL; ESOPHAGUS; HELICOBACTER PYLORI; HUMAN; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANTIOXIDANTS; ASCORBIC ACID; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL EXTRACTS; CELL LINE, TUMOR; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; ENZYME INHIBITORS; EPITHELIAL CELLS; ESOPHAGUS; FLAVONOIDS; HELICOBACTER PYLORI; HUMANS; IMIDAZOLES; INTERLEUKIN-8; MAP KINASE KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; PHOSPHORYLATION; PYRIDINES; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1;

EID: 33646029063     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gassur.2005.09.003     Document Type: Article

References (34)

1. Parsonnet J. Helicobacter pylori: The size of the problem. Gut 43 Suppl 1 (1998) S6
2. Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum 61 (1994) 1-241
3. Hosking S.W., Ling T.K., Chung S.C., et al. Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment. Randomised controlled trial. Lancet 343 (1994) 508-510
4. Torrado J., Ruiz B., Garay J., et al. Blood-group phenotypes, sulfomucins, and Helicobacter pylori in Barrett's esophagus. Am J Surg Pathol 21 (1997) 1023-1029
5. Wright T.A., Myskow M., and Kingsnorth A.N. Helicobacter pylori colonization of Barrett's esophagus and its progression to cancer. Dis Esophagus 10 (1997) 196-200
6. Goldblum J.R., Vicari J.J., Falk G.W., et al. Inflammation and intestinal metaplasia of the gastric cardia: The role of gastroesophageal reflux and H pylori infection. Gastroenterology 114 (1998) 633-639
7. Voutilainen M., Farkkila M., Mecklin J.P., Juhola M., and Sipponen P. Chronic inflammation at the gastroesophageal junction (carditis) seems to be a specific finding related to Helicobacter pylori infection and gastroesophageal reflux disease. The Central Finland Endoscopy Study Group. Am J Gastroenterol 94 (1999) 3175-3180
8. Graham D.Y. Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: A model. Gastroenterology 113 (1997) 1983-1991
9. El-Omar E.M., Oien K., El-Nujumi A., et al. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 113 (1997) 15-24
10. Manes G., Mosca S., Laccetti M., Lioniello M., and Balzano A. Helicobacter pylori infection, pattern of gastritis, and symptoms in erosive and nonerosive gastroesophageal reflux disease. Scand J Gastroenterol 34 (1999) 658-662
11. Labenz J., and Malfertheiner P. Helicobacter pylori in gastro-oesophageal reflux disease: Causal agent, independent or protective factor?. Gut 41 (1997) 277-280
12. Vicari J.J., Peek R.M., Falk G.W., et al. The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology 115 (1998) 50-57
13. Chow W.H., Blaser M.J., Blot W.J., et al. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res 58 (1998) 588-590
14. Kopp E.B., and Ghosh S. NF-κB and Rel proteins in innate immunity. Adv Immunol 58 (1995) 1-27
15. Baeuerle P.A., and Henkel T. Function and activation of NF-κB in the immune system. Annu Rev Immunol 12 (1994) 141-179
16. Abdel-Latif M.M., O'Riordan J., Windle H.J., et al. NF-kappaB activation in esophageal adenocarcinoma: Relationship to Barrett's metaplasia, survival, and response to neoadjuvant chemoradiotherapy. Ann Surg 239 (2004) 491-500
17. Jones A.D., Bacon K.D., Jobe B.A., Sheppard B.C., Deveney C.W., and Rutten M.J. Helicobacter pylori induces apoptosis in Barrett's-derived esophageal adenocarcinoma cells. J Gastrointest Surg 7 (2003) 68-76
18. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1979) 248-254
19. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 297 (1970) 680-685
20. Osborn L., Kunkel S., and Nabel G.J. Tumor necrosis factor alpha and interleukin-1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Pro Natl Acad Sci USA 86 (1989) 2336-2340
21. Whitmarsh A.J., and Davis R.J. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J Mol Med 74 (1996) 589-607
22. Cave D.R., and Vargas M. Effect of a Campylobacter pylori protein on acid secretion by parietal cells. Lancet ii (1989) 187-189
23. Konturek S.J., Konturek P.J., Brzozowski T., Stachnura J., and Zombala M. Gastric mucosal damage and adaptive protection by ammonia and ammonium ions in rats. Digestion 57 (1996) 433-445
24. Kim J.S., Kim J.M., Jung H.C., and Song I.S. Expression of cyclooygenase-2 in human neutophils activated by Helicobacter pylori water-soluble proteins: Possible involvement of NF-kappaB and MAP kinase signalling pathway. Dig Dis Sci 46 (2001) 2277-2284
25. Matsumoto K., Hashimoto S., Gon Y., Nakayama T., and Horie T. Proinflammatory cytokine-induced and chemical mediator-induced IL-8 expression in human bronchial epithelial cells through p38 mitogen-activated protein kinase-dependent pathway. J Allergy Clin Immunol 101 (1998) 825-831
26. Laine L., Cominelli F., Sloane R., Casini-Raggi V., and Marin-Sorensen M. Interaction of NSAIDs and Helicobacter pylori on gastrointestinal injury and prostaglandin production: A controlled double-blind trial. Aliment Pharmacol Ther 9 (1995) 127-135
27. Wilson K.T., Ramanujam K.S., Mobley H.L.T., Musselman R.F., James S.P., and Meltzer S.J. Helicobacter pylori stimulates inducible nitric oxide synthase expression and activity in a murine macrophage cell line. Gastroenterology 111 (1996) 1524-1533
28. Noach L.A., Bosma N.B., Jansen J., Hoek F.J., van Deventer S.J., and Tytgat G.N. Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol 29 (1994) 425-429
29. Genta R.M., Huberman R.M., and Graham D.Y. The gastric cardia in Helicobacter pylori infection. Hum Pathol 25 (1994) 915-919
30. Preikseitis H.G., Tremblay L., and Diamant N.E. Nitric oxide mediates inhibitory nerve effects in human esophagus and lower esophageal sphincter. Dig Dis Sci 39 (1994) 770-775
31. Mukhopadhyyay A., Rattan S., and Goyal R.K. Effect of prostaglandin E2 on esophageal motility in man. J Appl Physiol 39 (1975) 479-481
32. Keates S., Hitti Y.S., Upton M., and Kelly C.P. Helicobacter pylori infection activates NF-κB in gastric epithelial cells. Gastroenterology 113 (1998) 1099-1109
33. Wetscher G.J., Hinder P.R., Bagchi D., et al. Free radical scavengers prevent reflux esophagitis in rats. Dig Dis Sci 40 (1995) 1292-1296
34. Oh T.Y., Lee J.S., Ahn B.O., et al. Oxidative stress is more important than acid in the pathogenesis of reflux oesophagitis in rats. Gut 49 (2001) 364-371